Silk-based drug delivery system
    2.
    发明授权

    公开(公告)号:US10548981B2

    公开(公告)日:2020-02-04

    申请号:US14095366

    申请日:2013-12-03

    IPC分类号: A61K9/24 A61K9/00 A61K47/42

    摘要: The present invention provides for novel sustained release silk-based delivery systems. The invention further provides methods for producing such formulations. In general, a silk fibroin solution is combined with a therapeutic agent to form a silk fibroin article. The article is then treated in such a way as to alter its conformation. The change in conformation increases its crystallinity or liquid crystallinity, thus controlling the release of a therapeutic agent from the formulation. This can be accomplished as single material carriers or in a layer-by-layer fashion to load different therapeutic agents or different concentrations of these agents in each layer.

    SILK-BASED DRUG DELIVERY SYSTEM
    3.
    发明申请
    SILK-BASED DRUG DELIVERY SYSTEM 审中-公开
    基于SILK的药物递送系统

    公开(公告)号:US20140093580A1

    公开(公告)日:2014-04-03

    申请号:US14095366

    申请日:2013-12-03

    IPC分类号: A61K47/42

    摘要: The present invention provides for novel sustained release silk-based delivery systems. The invention further provides methods for producing such formulations. In general, a silk fibroin solution is combined with a therapeutic agent to form a silk fibroin article. The article is then treated in such a way as to alter its conformation. The change in conformation increases its crystallinity or liquid crystallinity, thus controlling the release of a therapeutic agent from the formulation. This can be accomplished as single material carriers or in a layer-by-layer fashion to load different therapeutic agents or different concentrations of these agents in each layer.

    摘要翻译: 本发明提供了新颖的持续释放的基于丝的递送系统。 本发明还提供了生产这种制剂的方法。 通常,将丝素蛋白溶液与治疗剂组合以形成丝素蛋白制品。 然后对该文章进行处理,以改变其构象。 构象的变化增加其结晶度或液晶性,从而控制治疗剂从制剂中的释放。 这可以作为单一材料载体或以逐层方式实现,以在每个层中加载不同的治疗剂或不同浓度的这些试剂。

    SYSTEMS AND METHODS FOR HIGH-THROUGHPUT SCREENING AND ANALYSIS OF DRUG DELIVERY SYSTEMS IN VITRO

    公开(公告)号:US20220299494A1

    公开(公告)日:2022-09-22

    申请号:US17753312

    申请日:2020-08-28

    摘要: The present disclosure provides a method for screening drug delivery vehicles for use in delivering cargo via oral delivery. The method includes introducing a drug delivery vehicle comprising an imaging agent into a lumen of an artificial intestine system composed of a scaffold matrix material. The scaffold matrix material includes an interconnected network of pores, intestinal epithelial cells positioned on an inner surface of the lumen, and human-based cells positioned within the pores and surrounding the intestinal epithelial cells. The method includes maintaining the artificial intestine system in physiologically relevant conditions for a predetermined length of time, and detecting a color change induced by the imaging agent within at least a portion of the human-based cells.